Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells

Cell Cycle

Volumn 11, Issue 24, 2012, Pages 4642-4649

  Leontieva, Olga V ^a   Lenzo, Felicia ^a   Demidenko, Zoya N ^a   Blagosklonny, Mikhail V ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Aging; Cell cycle; Cyclins; MTOR; Rapamycin; Regenerative proliferative potential

Indexed keywords

CYCLIN D1; CYCLIN E; NUTLIN 3; PROTEIN P21; RAPAMYCIN;

ARTICLE; CELL AGING; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DIVISION; CELL GEROCONVERSION; CELL PROLIFERATION; CELL STRESS; CELLULAR PARAMETERS; DNA DAMAGE; ENDOREDUPLICATION; GENE OVEREXPRESSION; HUMAN; INHIBITION KINETICS; MITOSIS; MITOSIS INHIBITION; MITOTIC INCOMPETENCE; MITOTIC SLIPPAGE; NONHUMAN;

EID: 84871503188     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.22937     Document Type: Article

References (61)

1. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-40; PMID:17667954; http://dx.doi.org/10.1038/nrm2233.
2. Rodier F, Muñoz DP, Teachenor R, Chu V, Le O, Bhaumik D, et al. DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci 2011; 124:68-81; PMID:21118958; http://dx.doi.org/10.1242/jcs.071340.
3. Blagosklonny MV. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging. Aging (Albany NY) 2012; 4:159-65; PMID:22394614.
4. Demidenko ZN, Blagosklonny MV. Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 2008; 7:3355-61; PMID:18948731; http://dx.doi.org/10.4161/cc.7.21.6919.
5. Demidenko ZN, Blagosklonny MV. Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential. Aging (Albany NY) 2009; 1:1008-16; PMID:20157583.
6. Leontieva OV, Blagosklonny MV. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging (Albany NY) 2010; 2:924-35; PMID:21212465.
7. Demidenko ZN, Korotchkina LG, Gudkov AV, Blagosklonny MV. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci USA 2010; 107:9660-4; PMID:20457898; http://dx.doi.org/10.1073/pnas.1002298107.
8. Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010; 2:344-52; PMID:20606252.
9. Leontieva OV, Natarajan V, Demidenko ZN, Burdelya LG, Gudkov AV, Blagosklonny MV. Hypoxia suppresses conversion from proliferative arrest to cellular senescence. Proc Natl Acad Sci USA 2012; 109:13314-8; PMID:22847439; http://dx.doi.org/10.1073/pnas.1205690109.
10. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009; 460:392-5; PMID:19587680.
11. Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 2011; 66:191-201; PMID:20974732; http://dx.doi.org/10.1093/gerona/glq178.
12. Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, et al. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle 2011; 10:4230-6; PMID:22107964; http://dx.doi.org/10.4161/cc.10.24.18486.
13. Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, et al. Rapamycin extends maximal lifespan in cancer-prone mice. Am J Pathol 2010; 176:2092-7; PMID:20363920; http://dx.doi.org/10.2353/ajpath.2010. 091050.
14. Wilkinson JE, Burmeister L, Brooks SV, Chan CC, Friedline S, Harrison DE, et al. Rapamycin slows aging in mice. Aging Cell 2012; 11:675-82; PMID:22587563; http://dx.doi.org/10.1111/j.1474-9726.2012.00832.x.
15. Spong A, Bartke A. Rapamycin slows aging in mice. Cell Cycle 2012; 11:845; PMID:22356747; http://dx.doi.org/10.4161/cc.11.5.19607.
16. Blagosklonny MV. Aging and immortality: quasiprogrammed senescence and its pharmacologic inhibition. Cell Cycle 2006; 5:2087-102; PMID:17012837; http://dx.doi.org/10.4161/cc.5.18.3288.
17. Tsang CK, Qi H, Liu LF, Zheng XFS. Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today 2007; 12:112-24; PMID:17275731; http://dx.doi.org/10.1016/j.drudis.2006.12.008.
18. Blagosklonny MV. An anti-aging drug today: from senescence-promoting genes to anti-aging pill. Drug Discov Today 2007; 12:218-24; PMID:17331886; http://dx.doi.org/10.1016/j.drudis.2007.01.004.
19. Blagosklonny MV. Validation of anti-aging drugs by treating age-related diseases. Aging (Albany NY) 2009; 1:281-8; PMID:20157517.
20. Dazert E, Hall MN. mTOR signaling in disease. Curr Opin Cell Biol 2011; 23:744-55; PMID:21963299; http://dx.doi.org/10.1016/j.ceb.2011.09.003.
21. Bjedov I, Partridge L. A longer and healthier life with TOR down-regulation: genetics and drugs. Biochem Soc Trans 2011; 39:460-5; PMID:21428920; http://dx.doi.org/10.1042/BST0390460.
22. Zheng XF. Chemoprevention of age-related macular regeneration (AMD) with rapamycin. Aging (Albany NY) 2012; 4:375-6; PMID:22796653.
23. Blagosklonny MV. Prospective treatment of age-related diseases by slowing down aging. Am J Pathol 2012; 181:1142-6; PMID:22841821; http://dx.doi.org/10. 1016/j.ajpath.2012.06.024.
24. Duliæ V, Drullinger LF, Lees E, Reed SI, Stein GH. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci USA 1993; 90:11034-8; PMID:8248208; http://dx.doi.org/10.1073/pnas.90.23.11034.
25. Lucibello FC, Sewing A, Brüsselbach S, Bürger C, Müller R. Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J Cell Sci 1993; 105:123-33; PMID:8360268.
26. Gong J, Traganos F, Darzynkiewicz Z. Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication. Cell Growth Differ 1995; 6:1485-93; PMID:8562487.
27. Wong H, Riabowol K. Differential CDK-inhibitor gene expression in aging human diploid fibroblasts. Exp Gerontol 1996; 31:311-25; PMID:8706801; http://dx.doi.org/10.1016/0531-5565(95)00025-9.
28. Burton DG, Sheerin AN, Ostler EL, Smith K, Giles PJ, Lowe J, et al. Cyclin D1 overexpression permits the reproducible detection of senescent human vascular smooth muscle cells. Ann N Y Acad Sci 2007; 1119:20-31; PMID:18056951; http://dx.doi.org/10.1196/annals.1404.026.
29. Atadja P, Wong H, Veillete C, Riabowol K. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp Cell Res 1995; 217:205-16; PMID:7698220; http://dx.doi.org/10.1006/excr.1995.1080.
30. Darzynkiewicz Z. Another "Janus paradox" of p53: induction of cell senescence versus quiescence. Aging (Albany NY) 2010; 2:329-30; PMID:20603525.
31. Chang BD, Xuan Y, Broude EV, Zhu H, Schott B, Fang J, et al. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 1999; 18:4808-18; PMID:10490814; http://dx.doi.org/10.1038/sj.onc.1203078.
32. Chang BD, Broude EV, Fang J, Kalinichenko TV, Abdryashitov R, Poole JC, et al. p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 2000; 19:2165-70; PMID:10815808; http://dx.doi.org/ 10.1038/sj.onc.1203573.
33. Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8:1888-95; PMID:19471117; http://dx.doi.org/10.4161/cc.8.12.8606.
34. Leontieva OV, Blagosklonny MV. Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression. Aging (Albany NY) 2011; 3:1078-91; PMID:22156391.
35. Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov VA, Gudkov AV, Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle 2009; 8:4112-8; PMID:19946210; http://dx.doi.org/10.4161/cc.8.24.10215.
36. Darzynkiewicz Z. When senescence masquerades as DNA damage: is DNA replication stress the culprit? Cell Cycle 2009; 8:3810-1; PMID:19887905; http://dx.doi.org/10.4161/cc.8.23.10368.
37. Tanaka T, Kajstura M, Halicka HD, Traganos F, Darzynkiewicz Z. Constitutive histone H2AX phosphorylation and ATM activation are strongly amplified during mitogenic stimulation of lymphocytes. Cell Prolif 2007; 40:1-13; PMID:17227291; http://dx.doi.org/10.1111/j.1365-2184.2007.00417.x.
38. Halicka HD, Zhao H, Li J, Traganos F, Zhang S, Lee M, et al. Genome protective effect of metformin as revealed by reduced level of constitutive DNA damage signaling. Aging (Albany NY) 2011; 3:1028-38; PMID:22067284.
39. Anisimov VN. Metformin for aging and cancer prevention. Aging (Albany NY) 2010; 2:760-74; PMID:21084729.
40. Blagosklonny MV. Cell senescence and hypermitogenic arrest. EMBO Rep 2003; 4:358-62; PMID:12671679; http://dx.doi.org/10.1038/sj.embor.embor806.
41. Nelsen CJ, Rickheim DG, Tucker MM, Hansen LK, Albrecht JH. Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes. J Biol Chem 2003; 278:3656-63; PMID:12446670; http://dx.doi.org/10. 1074/jbc.M209374200.
42. Zacharek SJ, Xiong Y, Shumway SD. Negative regulation of TSC1-TSC2 by mammalian D-type cyclins. Cancer Res 2005; 65:11354-60; PMID:16357142; http://dx.doi.org/10.1158/0008-5472.CAN-05-2236.
43. Wang C, Lisanti MP, Liao DJ. Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology. Cell Cycle 2011; 10:57-67; PMID:21200143; http://dx.doi.org/10.4161/cc.10.1.14449.
44. Icreverzi A, de la Cruz AF, Van Voorhies WA, Edgar BA. Drosophila cyclin D/Cdk4 regulates mitochondrial biogenesis and aging and sensitizes animals to hypoxic stress. Cell Cycle 2012; 11:554-68; PMID:22293404; http://dx.doi.org/10. 4161/cc.11.3.19062.
45. Hanse EA, Mashek DG, Becker JR, Solmonson AD, Mullany LK, Mashek MT, et al. Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4 á . Cell Cycle 2012; 11:2681-90; PMID:22751438; http://dx.doi.org/10.4161/cc.21019.
46. Knudsen KE. Cyclin D1 goes metabolic: Dual functions of cyclin D1 in regulating lipogenesis. Cell Cycle 2012; 11:3534; PMID:22951541; http://dx.doi.org/10.4161/cc.22039.
47. Sengupta T, Abraham G, Xu Y, Clurman BE, Minella AC. Hypoxia-inducible factor 1 is activated by dysregulated cyclin E during mammary epithelial morphogenesis. Mol Cell Biol 2011; 31:3885-95; PMID:21746877; http://dx.doi.org/10.1128/MCB.05089-11.
48. Bagheri-Yarmand R, Biernacka A, Hunt KK, Keyomarsi K. Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification. Cancer Res 2010; 70:5074-84; PMID:20530685; http://dx.doi.org/10.1158/0008-5472.CAN-09-4094.
49. Bagheri-Yarmand R, Nanos-Webb A, Biernacka A, Bui T, Keyomarsi K. Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C. Cancer Res 2010; 70:5085-95; PMID:20530684; http://dx.doi.org/10.1158/ 0008-5472.CAN-09-4095.
50. Casimiro MC, Pestell RG. Cyclin d1 induces chromosomal instability. Oncotarget 2012; 3:224-5; PMID:22538871.
51. Bonda DJ, Evans TA, Santocanale C, Llosá JC, Viña J, Bajic VP, et al. Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease. Aging (Albany NY) 2009; 1:382-8; PMID:19946466.
52. Frade JM. Unscheduled re-entry into the cell cycle induced by NGF precedes cell death in nascent retinal neurones. J Cell Sci 2000; 113:1139-48; PMID:10704365.
53. Song B, Davis K, Liu XS, Lee HG, Smith M, Liu X. Inhibition of Polo-like kinase 1 reduces beta-amyloid-induced neuronal cell death in Alzheimer's disease. Aging (Albany NY) 2011; 3:846-51; PMID:21931181.
54. Frade JM, López-Sánchez N. A novel hypothesis for Alzheimer disease based on neuronal tetraploidy induced by p75 (NTR). Cell Cycle 2010; 9:1934-41; PMID:20436277; http://dx.doi.org/10.4161/cc.9.10.11582.
55. Futatsugi A, Utreras E, Rudrabhatla P, Jaffe H, Pant HC, Kulkarni AB. Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons. Cell Cycle 2012; 11:1603-10; PMID:22456337; http://dx.doi.org/10.4161/cc.20009.
56. Hixon ML, Gualberto A. Vascular smooth muscle polyploidization - from mitotic checkpoints to hypertension. Cell Cycle 2003; 2:105-10; PMID:12695657; http://dx.doi.org/10.4161/cc.2.2.341.
57. Jones MR, Ravid K. Vascular smooth muscle polyploidization as a biomarker for aging and its impact on differential gene expression. J Biol Chem 2004; 279:5306-13; PMID:14634004; http://dx.doi.org/10.1074/jbc.M308406200.
58. Enesco HE, Shimokawa I, Yu BP. Effect of dietary restriction and aging on polyploidy in rat liver. Mech Ageing Dev 1991; 59:69-78; PMID:1890887; http://dx.doi.org/10.1016/0047-6374(91)90074-A.
59. Fukazawa H, Uehara Y. U0126 reverses Ki-rasmediated transformation by blocking both mitogenactivated protein kinase and p70 S6 kinase pathways. Cancer Res 2000; 60:2104-7; PMID:10786668.
60. Demidenko ZN, Shtutman M, Blagosklonny MV. Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence. Cell Cycle 2009; 8:1896-900; PMID:19478560; http://dx.doi.org/10. 4161/cc.8.12.8809.
61. Demidenko ZN, Kalurupalle S, Hanko C, Lim CU, Broude E, Blagosklonny MV. Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis. Oncogene 2008; 27:4402-10; PMID:18469851; http://dx.doi.org/10.1038/onc.2008.82.